Lei Yang
Ningbo University(CN)St. Jude Children's Research Hospital(US)Huawei Technologies (China)(CN)Zhengzhou University(CN)Theranostics (New Zealand)(NZ)Io Therapeutics (United States)(US)
Publications by Year
Research Areas
Protein Degradation and Inhibitors, Multiple Myeloma Research and Treatments, Ubiquitin and proteasome pathways, Chromatin Remodeling and Cancer, Tuberculosis Research and Epidemiology
Most-Cited Works
- → Engineered bioorthogonal POLY-PROTAC nanoparticles for tumour-specific protein degradation and precise cancer therapy(2022)190 cited
- → Asparaginase May Influence Dexamethasone Pharmacokinetics in Acute Lymphoblastic Leukemia(2008)152 cited
- → Phenyl‐Glutarimides: Alternative Cereblon Binders for the Design of PROTACs(2021)145 cited
- → Tumor cellular proteasome inhibition and growth suppression by 8-hydroxyquinoline and clioquinol requires their capabilities to bind copper and transport copper into cells(2009)134 cited
- → Enhancement of cell recognition in vitro by dual-ligand cancer targeting gold nanoparticles(2011)113 cited
- → Heterocyclic-Fused Pyrimidines as Novel Tubulin Polymerization Inhibitors Targeting the Colchicine Binding Site: Structural Basis and Antitumor Efficacy(2018)105 cited